InspireMD Net Debt vs Capital Stock Analysis
NSPR Stock | USD 2.30 0.08 3.36% |
InspireMD financial indicator trend analysis is infinitely more than just investigating InspireMD recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether InspireMD is a good investment. Please check the relationship between InspireMD Net Debt and its Capital Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.
Net Debt vs Capital Stock
Net Debt vs Capital Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of InspireMD Net Debt account and Capital Stock. At this time, the significance of the direction appears to have almost no relationship.
The correlation between InspireMD's Net Debt and Capital Stock is 0.19. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Capital Stock in the same time period over historical financial statements of InspireMD, assuming nothing else is changed. The correlation between historical values of InspireMD's Net Debt and Capital Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of InspireMD are associated (or correlated) with its Capital Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Stock has no effect on the direction of Net Debt i.e., InspireMD's Net Debt and Capital Stock go up and down completely randomly.
Correlation Coefficient | 0.19 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Capital Stock
The total amount of a company’s capital funded by shareholders through the issue and subscription of shares.Most indicators from InspireMD's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into InspireMD current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.At this time, InspireMD's Tax Provision is relatively stable compared to the past year. As of 05/18/2024, Sales General And Administrative To Revenue is likely to grow to 2.31, while Issuance Of Capital Stock is likely to drop slightly above 27.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Cost Of Revenue | 3.7M | 4.1M | 4.4M | 3.1M | Research Development | 5.2M | 7.8M | 8.0M | 4.3M |
InspireMD fundamental ratios Correlations
Click cells to compare fundamentals
InspireMD Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InspireMD fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 9.9M | 17.8M | 39.7M | 24.7M | 47.6M | 50.0M | |
Other Current Liab | 2.1M | 3.1M | 3.0M | 4.0M | 4.5M | 2.7M | |
Total Current Liabilities | 3.1M | 3.7M | 4.3M | 5.1M | 6.0M | 4.2M | |
Total Stockholder Equity | 5.4M | 12.2M | 33.5M | 17.4M | 39.5M | 41.5M | |
Net Debt | (4.9M) | (11.6M) | (10.8M) | (3.0M) | (9.6M) | (9.2M) | |
Retained Earnings | (157.6M) | (168.2M) | (183.1M) | (201.6M) | (221.5M) | (210.4M) | |
Cash | 5.5M | 12.6M | 12.0M | 4.6M | 9.6M | 7.6M | |
Cash And Short Term Investments | 5.5M | 12.6M | 34.0M | 17.8M | 39.0M | 41.0M | |
Common Stock Shares Outstanding | 139.3K | 1.5M | 7.3M | 7.9M | 24.3M | 25.5M | |
Liabilities And Stockholders Equity | 9.9M | 17.8M | 39.7M | 24.7M | 47.6M | 50.0M | |
Other Stockholder Equity | 163.0M | 180.3M | 216.6M | 219.0M | 261M | 138.1M | |
Total Liab | 4.5M | 5.6M | 6.2M | 7.3M | 8.1M | 6.9M | |
Total Current Assets | 7.8M | 15.3M | 37.1M | 21.3M | 44.2M | 46.4M | |
Non Current Assets Total | 2.1M | 2.4M | 2.6M | 3.3M | 3.5M | 2.0M | |
Non Currrent Assets Other | 586K | 725K | 905K | 856K | 951K | 654.2K | |
Net Receivables | 973K | 945K | 1.4M | 1.2M | 1.8M | 1.0M | |
Non Current Liabilities Total | 1.4M | 1.9M | 1.8M | 2.2M | 2.1M | 2.1M | |
Inventory | 1.2M | 1.4M | 1.1M | 1.6M | 2.1M | 1.2M | |
Property Plant And Equipment Gross | 421K | 1.5M | 1.7M | 2.5M | 4.6M | 4.8M | |
Other Liab | 729K | 910K | 1.1M | 995K | 1.1M | 738.6K | |
Property Plant And Equipment Net | 421K | 1.5M | 1.7M | 2.5M | 2.5M | 2.7M | |
Accounts Payable | 646K | 236K | 893K | 659K | 939K | 570.7K | |
Other Assets | 586K | 725K | 905K | 856K | 984.4K | 506K | |
Retained Earnings Total Equity | (140.4M) | (147.6M) | (157.6M) | (168.2M) | (151.4M) | (158.9M) | |
Other Current Assets | 87K | 334K | 522K | 15.1M | 3.0M | 1.6M | |
Property Plant Equipment | 547K | 448K | 1.7M | 2.5M | 2.8M | 3.0M | |
Net Tangible Assets | 5.4M | 12.2M | 33.5M | 17.4M | 20.0M | 21.0M | |
Capital Surpluse | 143.1M | 156.4M | 163.0M | 180.3M | 207.4M | 157.7M | |
Non Current Liabilities Other | 624K | 605K | 1.4M | 1.9M | 2.2M | 2.3M | |
Net Invested Capital | 5.4M | 12.2M | 33.5M | 17.4M | 39.5M | 41.5M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in InspireMD. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
CEOs Directory Screen CEOs from public companies around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.